Overview

Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection

Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Treatment of patients hospitalised for management of moderate COVID-19 infection
Phase:
Phase 3
Details
Lead Sponsor:
PharmaMar
Treatments:
Dexamethasone
Favipiravir
Remdesivir